Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients
Launched by XUANWU HOSPITAL, BEIJING · May 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and predicting the risk of postoperative delirium and long-term cognitive issues in elderly patients after surgery. Postoperative delirium is a temporary state of confusion that can happen after an operation, and it may lead to longer-lasting problems with thinking and memory. The researchers are using advanced technology, including artificial intelligence, to analyze a large amount of medical data. Their goal is to develop a system that can identify patients at high risk for these complications, allowing for earlier intervention and better care.
To participate in this trial, patients need to be at least 65 years old and have undergone surgery with anesthesia. They must also be able to give informed consent, meaning they understand the study and agree to take part. However, individuals with certain medical conditions, like severe mental health issues or cognitive impairments, will not be included. Participants can expect to contribute to important research that may improve care for older adults undergoing surgery, and they will be monitored closely for any signs of confusion or cognitive changes during their recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients ≥65 years of age who have undergone surgical anesthesia; Sign informed consent
- Exclusion Criteria:
- • Inability to complete cognitive function assessment; Illiteracy, hearing impairment or visual impairment; He has a history of epilepsy, depression, schizophrenia, Alzheimer's disease and other psychiatric and neurological diseases
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
lei zhao
Study Chair
xuanwu hospital of capital medical university,Beijing
yong yang
Principal Investigator
Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences
yi an
Principal Investigator
xuanwu hospital of capital medical university,Beijing
xia li li
Principal Investigator
xuanwu hospital of capital medical university,Beijing
yang liu
Principal Investigator
xuanwu hospital of capital medical university,Beijing
yi shu yang
Principal Investigator
xuanwu hospital of capital medical university,Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported